A Swedish study finds different survival times across ventilation pathways in ALS
Original source
Home mechanical ventilation for amyotrophic lateral sclerosis-a national study of survival and treatment trends across 27 years. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Studied in
- Human
Population inferred from the title and abstract by Compass.
A 27-year Swedish registry study of 1,360 people with amyotrophic lateral sclerosis (ALS) found that initial non-invasive ventilation was the most common home mechanical ventilation strategy. Median observed survival was 1.7 years with non-invasive ventilation, 4.9 years with invasive ventilation, and 6.5 years among those who transitioned from non-invasive to invasive ventilation. Most invasive ventilation starts were unplanned, and use varied substantially by region.
Why this matters
The findings describe treatment patterns and outcomes for people with ALS receiving home ventilation in Sweden. They do not show that invasive ventilation causes longer survival, because the study was observational and the groups may have differed in disease course, selection and other factors. The results may help clinicians and families discuss planning for ventilation, but they do not by themselves change treatment recommendations.
Limitations and context
This was a retrospective, registry-based cohort study from Sweden covering 1996–2022, not a randomised trial. Survival differences may reflect patient selection and underlying disease trajectory as well as ventilation strategy. Regional patterns and results may not apply to other healthcare systems or populations. The source is a primary journal article, and the supplied information does not indicate whether the findings are preliminary or subject to correction.